Skip to main content
Premium Trial:

Request an Annual Quote

AnaSpec, Monogram Biosciences

Premium
AnaSpec this week released its latest series of Protease or Proteinase-Activated Receptors, or PAR, peptides. A total of 17 new PARs were launched.
 

 
Monogram Biosciences said this week that beginning July 15 its HERmark Breast Cancer Assay will be available to doctors for assessing HER2 status in patients with breast cancer.
 
The assay provides a “precise and quantitative” measurement of HER2 total protein and HER2 homodimer levels, according to the company. HERmark will be offered as a CLIA-validated assay through Monogram’s CAP-certified clinical laboratory.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.